153 related articles for article (PubMed ID: 27983533)
1. Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment.
Huang XH; Liang RH; Su L; Guo W; Wang CJ
Cancer Biomark; 2017; 18(2):183-190. PubMed ID: 27983533
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine Bushen-Jianpi-Huoxue decoction prevents diabetic osteoporosis in rats via Wnt and nuclear factor-kappa B signaling pathways.
Zhang Y; Liu M; Li H; Chen Z; Liang N; Xu J; Zhang X; Zhang Y
Int J Rheum Dis; 2017 Aug; 20(8):941-948. PubMed ID: 28294540
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.
Liu P; Yang DQ; Xie F; Zhou B; Liu M
Genet Mol Res; 2014 Jul; 13(3):5285-91. PubMed ID: 25078584
[TBL] [Abstract][Full Text] [Related]
4. Effect of Jianpi Bushen formula on aromatase-inhibitor-associated bone loss after menopause.
Dai Y; Chen Q; Guan R; Xu R; Qiu C; Song X; Guo Q; Wang Z; Chen Q; Wang Z
J Tradit Chin Med; 2018 Dec; 38(6):879-889. PubMed ID: 32186135
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
Yonehara Y; Iwamoto I; Kosha S; Rai Y; Sagara Y; Douchi T
J Obstet Gynaecol Res; 2007 Oct; 33(5):696-9. PubMed ID: 17845332
[TBL] [Abstract][Full Text] [Related]
6. [Effect of bushen jianpi decoction and its disassemble recipes on tumor growth in mice with transplanted primary hepatic carcinoma].
Zhong Y; Luo CL; An-Jun Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):213-7. PubMed ID: 21425577
[TBL] [Abstract][Full Text] [Related]
7. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
Nakamura Y; Hayashi K; Abu-Ali S; Naito M; Fotovati A
J Bone Joint Surg Am; 2008 Apr; 90(4):824-32. PubMed ID: 18381321
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo.
Wright LE; Harhash AA; Kozlow WM; Waning DL; Regan JN; She Y; John SK; Murthy S; Niewolna M; Marks AR; Mohammad KS; Guise TA
Oncotarget; 2017 Jan; 8(5):8406-8419. PubMed ID: 28039445
[TBL] [Abstract][Full Text] [Related]
9. The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.
Li F; Chow S; Cheung WH; Chan FL; Chen S; Leung LK
J Nutr Biochem; 2013 Jun; 24(6):1112-6. PubMed ID: 23238426
[TBL] [Abstract][Full Text] [Related]
10. Bu-Shen-Ning-Xin Decoction ameliorated the osteoporotic phenotype of ovariectomized mice without affecting the serum estrogen concentration or uterus.
Wang L; Qiu XM; Gui YY; Xu YP; Gober HJ; Li DJ
Drug Des Devel Ther; 2015; 9():5019-31. PubMed ID: 26357466
[TBL] [Abstract][Full Text] [Related]
11. The fixed herbal drug composition "Saikokaryukotsuboreito" prevents bone loss with an association of serum IL-6 reductions in ovariectomized mice model.
Hattori T; Fei W; Kizawa T; Nishida S; Yoshikawa H; Kishida Y
Phytomedicine; 2010 Mar; 17(3-4):170-7. PubMed ID: 20097049
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Er-xian decoction on femur proteomics in ovariectomized osteoporosis rats].
Liu ZW; Liu B; Wu Q; Chen YF; Xu P; Xie HH; Wang Y; Yang S
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2558-2563. PubMed ID: 28840699
[TBL] [Abstract][Full Text] [Related]
13. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats.
Zhao X; Wu ZX; Zhang Y; Yan YB; He Q; Cao PC; Lei W
J Ethnopharmacol; 2011 Oct; 137(3):1083-8. PubMed ID: 21782010
[TBL] [Abstract][Full Text] [Related]
14. Antiosteoporotic activity of echinacoside in ovariectomized rats.
Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
[TBL] [Abstract][Full Text] [Related]
15. Antiosteoporotic activity of icariin in ovariectomized rats.
Nian H; Ma MH; Nian SS; Xu LL
Phytomedicine; 2009 Apr; 16(4):320-6. PubMed ID: 19269147
[TBL] [Abstract][Full Text] [Related]
16. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
Eastell R; Hannon RA; Cuzick J; Dowsett M; Clack G; Adams JE;
J Bone Miner Res; 2006 Aug; 21(8):1215-23. PubMed ID: 16869719
[TBL] [Abstract][Full Text] [Related]
17. Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
Tang SC
Oncology; 2010; 79(1-2):13-26. PubMed ID: 21051913
[TBL] [Abstract][Full Text] [Related]
18. Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.
Gibson K; O'Bryant CL
J Oncol Pharm Pract; 2008 Sep; 14(3):139-45. PubMed ID: 18719068
[TBL] [Abstract][Full Text] [Related]
19. Aromatase and breast cancer.
Brodie A; Sabnis G; Jelovac D
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):97-102. PubMed ID: 17113978
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats].
Xing GS; Lou JS; Wang ZB; Yu SL; Wang Y; Sheng L
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1909-13. PubMed ID: 18051905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
